Kyle Piskel insider trades

Open-market stock purchases and sales by Kyle Piskel, Chief Financial Officer at Adaptive Biotechnologies Corp, from SEC Form 4 filings since Nov 15, 2021.

Recent trades

DateStockTradeValue
May 18, 2026ADPT Adaptive Biotechnologies CorpSold$40.6K
Mar 11, 2026ADPT Adaptive Biotechnologies CorpSold$246K
Mar 4, 2026ADPT Adaptive Biotechnologies CorpBought (not open market)—
Feb 4, 2026ADPT Adaptive Biotechnologies CorpSold$39.6K
Feb 4, 2026ADPT Adaptive Biotechnologies CorpBought (not open market)—
Jan 12, 2026ADPT Adaptive Biotechnologies CorpSold$77.2K
Jan 12, 2026ADPT Adaptive Biotechnologies CorpBought (not open market)—
Nov 28, 2025ADPT Adaptive Biotechnologies CorpSold$3.2M
Nov 28, 2025ADPT Adaptive Biotechnologies CorpBought (not open market)—
Nov 28, 2025ADPT Adaptive Biotechnologies CorpBought (not open market)—
Nov 28, 2025ADPT Adaptive Biotechnologies CorpBought (not open market)—
Nov 17, 2025ADPT Adaptive Biotechnologies CorpSold$3.3K

Companies traded

  • ADPT Adaptive Biotechnologies Corp: 19 sales, last May 18, 2026

Get free alerts when Kyle Piskel files a new trade →